Using this cell model, we demonstrate that 7,8-DHF, quercetin, and apigenin target HSPB1, NRF2, and TRKB to reduce Tau aggregation and protect cells against Tau neurotoxicity, providing new treatment strategies for AD. Here, NFE2L2 is linked to Alzheimer disease.